Treatment
Medication clinical trials
We’re tracking 7,138 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT07820670Recruiting
Blood thinner choice after cesarean section to prevent blood clots
This study compares two blood-thinner medicines given after a C-section to see which one works better at preventing dangerous blood clots. It may help women who are at higher risk for clots rest easier right after delivery.
HolonAges 18–50 - NCT07817381Recruiting
Resistance and loading exercise for bone health
This trial tests a supervised exercise program with weights and jumping activities to improve bone health in males with one leg amputated below the knee. If you're already using a prosthetic leg and walking well, this study might help strengthen your bones.
LoughboroughAges 18–55 - NCT06477614RecruitingPhase 1
Personalized vaccine for advanced solid tumors
This trial tests a personalized vaccine made from your own immune cells (dendritic cells) to help your body fight advanced cancer. It is for people whose cancer has not responded to other treatments.
Guanzhou, GuangdongAges 18–80 - NCT00640107Recruiting
Check how well ultrasound and MRI work on volunteers
This study tests and improves the equipment and computer settings used for ultrasound and MRI scans. It may help make these scans clearer and more reliable in the future for people who need them.
Syracuse, New YorkAges 18–70 - NCT06454448RecruitingPhase 1/Phase 2
Adebrelimab plus chemotherapy for advanced pancreatic cancer
This trial tests a combination of a targeted immune therapy (Adebrelimab) with three chemotherapy drugs for people with metastatic pancreatic cancer who haven't had any treatment yet. The goal is to see if this combination can shrink tumors and help people live longer.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT07824323RecruitingPhase 4
Early cholesterol treatment after a heart attack
This study tests whether adding an extra cholesterol-lowering drug (bempedoic acid) to the usual treatment soon after a heart attack or related event can lower 'bad' cholesterol more effectively. It may help reduce the risk of future heart problems.
Taipei, Taipei CityAges 18 years+ - NCT07825831Recruiting
Personalized heat-risk alerts for chronic conditions
This study uses AI to send personalized heat warnings to people with chronic health conditions like high blood pressure, diabetes, or obesity. The goal is to help you avoid heat-related health problems during the six-week program.
Gujranwala, Punjab ProvinceAges 18 years+ - NCT07823036RecruitingPhase 1/Phase 2
MRI scans of lungs after stem cell transplant
This study uses MRI scans to look at the lungs in people who have had a stem cell transplant (HSCT). It will help doctors understand and detect early lung problems, so they can act sooner.
Cincinnati, OhioAges 3 years+ - NCT07824401Recruiting
Dignity therapy for older adults in long-term care
This study tests whether a talking therapy called dignity therapy can help older adults in nursing homes feel more valued and at peace. It may boost your sense of purpose and emotional well-being.
Kaohsiung CityAges 65 years+ - NCT07823816Enrolling by invitation
Lung-protective ventilation for stomach removal surgery
This study tests a type of breathing support during surgery to remove the stomach (gastrectomy) that may protect the lungs. It aims to see if this approach reduces complications and helps patients recover better.
Ho Chi Minh City, Ho Chi MinhAges 18–70 - NCT07820410RecruitingPhase 2/Phase 3
Atrial shunt for heart failure with reduced pumping function
This study tests a small device that creates a tiny opening inside the heart to help lower pressure and improve symptoms in people with heart failure. The procedure is minimally invasive and aims to reduce hospitalizations and improve quality of life.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07823010Enrolling by invitationPhase 1/Phase 2
Xenon gas MRI scan study for children
This study is developing a new type of MRI scan that uses xenon gas to take pictures of the lungs. It may help doctors see how well your lungs are working without any radiation.
Cincinnati, OhioAges Any age - NCT07822347Enrolling by invitationPhase 1/Phase 2
Study of a new treatment for advanced tumors with low oxygen
This trial tests a new drug that targets tumors with a specific marker you can see on a PET scan. It is for people whose cancer has spread or come back after standard treatments, and it may help shrink tumors or slow their growth.
Beijing, Beijing MunicipalityAges 18–80 - NCT07822178Enrolling by invitation
How the brain understands faces during epilepsy monitoring
This study looks at how the brain understands faces by recording brain activity while you look at pictures. It uses the electrodes already placed in your brain during epilepsy monitoring, so no extra procedures are needed.
Los Angeles, CaliforniaAges 18 years+ - NCT07819656Recruiting
Predicting severe blood cell drops in nasopharyngeal cancer
This study looks at how likely it is for people with nasopharyngeal carcinoma to experience a severe drop in blood cell counts (myelosuppression) during treatment. By tracking risk, doctors may be better able to prevent or manage this side effect.
Guangzhou, GuangdongAges 18 years+ - NCT07818239Enrolling by invitation
How diet affects eye blood vessels
This study looks at how different foods and drinks affect the blood vessels in your eyes. By taking pictures of your retina (the back of the eye) after certain meals, researchers hope to learn more about diet and eye health.
ViennaAges 18 years+ - NCT07819916Recruiting
Exercises for flexible flat feet without pain
This trial tests a specific set of exercises to see if they can improve flexible flat feet. It may help if you have flat feet that are not painful and can flex.
LahoreAges 20–40 - NCT06485271Recruiting
Camrelizumab for advanced gastric cancer
This trial tests a drug called camrelizumab, alone or with other treatments, for people with advanced stomach cancer that has worsened or returned. It aims to see how well this treatment works in real-world patients.
Changzhi, ShanxiAges 18–75 - NCT06482801RecruitingPhase 2
Immunotherapy combo for newly treated liver cancer
This trial tests a combination of immunotherapy drugs given directly into the liver’s blood supply as a first treatment for liver cancer. It aims to see if this approach can shrink tumors and improve outcomes for people with relatively preserved liver function.
GuangzhouAges 18–75 - NCT04614961Recruiting
Obesity clinic patient database study
This study collects information about people who visit an obesity clinic. It aims to better understand patients’ health and care needs, which may improve future treatment.
LeuvenAges 18 years+ - NCT02445534Recruiting
Registry for cell therapy in non-ischemic dilated heart muscle disease
This is a research registry that follows people with non-ischemic dilated cardiomyopathy (a weakened heart muscle) who are already on the right medications. It helps doctors better understand how cell-based therapy and related care affect heart function over time.
LjubljanaAges 18–65 - NCT05592717Recruiting
YUTIQ implant for chronic non-infectious eye inflammation
This trial tests whether a small steroid implant placed inside the eye (YUTIQ 0.18 mg) can control chronic non-infectious uveitis. It may help reduce active inflammation and prevent flare-ups, as long as you’ve had recent signs of active disease and can follow the medication and eye-visit rules.
Tianjin, Tianjin MunicipalityAges 18–70 - NCT06317558Recruiting
Real-world study of immunotherapy before surgery for lung cancer
This study looks at how well immunotherapy given before surgery works for non-small cell lung cancer. It aims to help doctors understand real-world outcomes for patients who receive this treatment.
Beijing, Beijing MunicipalityAges 18–85 - NCT06298968RecruitingPhase 2
Study of chemo, targeted therapy, and immunotherapy for bile duct cancer
This trial tests a combination of chemotherapy (gemcitabine and cisplatin) with the targeted therapy lenvatinib and the immunotherapy adebrelimab for people with advanced bile duct cancer that cannot be removed by surgery. It aims to see if this combination works better than standard treatments.
Guangzhou, GuangdongAges 18–75
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,138 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.